OPTIMISING THE SUPPLY CHAIN OF MEDICAL DEVICES: PHARMACEUTICAL CLASSIFICATION AND QUALITY MANAGEMENT
GM-022
USING AN INTEGRATED INFORMATION SYSTEM TO REDUCE INTERRUPTIONS AND THE NUMBER OF NON-RELEVANT CONTACTS IN THE INPATIENT PHARMACY AT TERTIARY HOSPITAL
GM-035
CAN ADMINSTRATION TRACEABILITY OF BLOOD DERIVED MEDICINES BY PARAMEDICAL TEAM BE OPTIMAL WITHOUT INTERVENTION OF THE PHARMACEUTICAL TEAM?
GM-034
OPTIMISATION OF THE BLOOD DERIVED MEDICINES CIRCUIT BY COLLECTING AND ANALYZING NON-COMPLIANCES
GM-029
CHARACTERISTICS OF WORK INTERRUPTIONS DURING MEDICATION ADMINISTRATION
GM-026
QUALITY MANAGEMENT SYSTEM IN CYTOTOXIC DRUGS LABORATORY: MONITORING ACTIVITY AND IMPROVEMENT ACTIONS
GM-025
EVIDENCES ABOUT THE ROLES AND THE IMPACT OF PHARMACISTS: AN ACTION PLAN OF INTERVENTIONS TO INCREASE PHARMACIST AWARENESS ABOUT THESE EVIDENCES
GM-023
PERFORMANCE INDICATORS IN HOSPITAL PHARMACY: EXPERIENCE OF A TEACHING HOSPITAL WITH A DOCUMENTATION TOOL
GM-023
PERFORMANCE INDICATORS IN HOSPITAL PHARMACY: EXPERIENCE OF A TEACHING HOSPITAL WITH A DOCUMENTATION TOOL
GM-018
SHARING DRUG INFORMATION TO OPTIMISE PRESCRIBING AND ADMINISTRATION OF MEDICINES FOR HOSPITALISED PATIENTS: FROM THEORY TO DAILY PRACTICE
GM-017
THE ANNUAL COSTS OF PREPARING THE TOP 10 MOST COMMONLY USED INJECTABLE DRUGS AS PREFILLED SYRINGES IN A HOSPITAL PHARMACY
GM-013
PHARMACEUTICAL SUPPORT ROLE OF HOSPITAL PHARMACY DEPARTMENT IN CENTRAL ITALY EARTHQUAKE
GM-012
PHARMACOECONOMICS EVALUATION OF IMPLANTATION THE SELECTIVE DIGESTIVE TRACT DECONTAMINATION FOR PREVENTION OF VENTILATOR-ASSOCIATED PNEUMONIA IN A CRITICAL CARE UNIT
GM-011
CONTAMINATION WITH CYTOSTATICS IN PHARMACIES AND HOSPITALS IN THE CZECH REPUBLIC
GM-009
ROLE AND IMPACT OF HOSPITAL PHARMACY TECHNICIAN: A LITERATURE REVIEW
